Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 118543-96-7 | MDL No. : | MFCD18377786 |
Formula : | C7H6N2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HMUCEWYEXBWAGY-UHFFFAOYSA-N |
M.W : | 166.13 | Pubchem ID : | 45082593 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 39.19 |
TPSA : | 80.15 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.55 cm/s |
Log Po/w (iLOGP) : | 0.71 |
Log Po/w (XLOGP3) : | -0.34 |
Log Po/w (WLOGP) : | 0.38 |
Log Po/w (MLOGP) : | -1.44 |
Log Po/w (SILICOS-IT) : | 0.56 |
Consensus Log Po/w : | -0.03 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -0.89 |
Solubility : | 21.2 mg/ml ; 0.128 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.88 |
Solubility : | 21.8 mg/ml ; 0.131 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.35 |
Solubility : | 7.35 mg/ml ; 0.0443 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.93 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338-P310 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 72797-17-2 ]
2-Acetyl-3,5(6)-dimethylpyrazine, mixture of isomers
Similarity: 0.72
[ 916333-43-2 ]
5-Acetylpyrazine-2-carbonitrile
Similarity: 0.69
[ 1159813-33-8 ]
1-(5-Hydroxypyrazin-2-yl)ethanone
Similarity: 0.55
[ 132426-19-8 ]
2-Bromo-1-(pyrazin-2-yl)ethanone
Similarity: 0.54
[ 13515-06-5 ]
5,6-Dimethylpyrazine-2-carboxylic acid
Similarity: 0.86
[ 940-07-8 ]
Pyrazine-2,6-dicarboxylic acid
Similarity: 0.84
[ 205692-63-3 ]
Pyrazine-2,5-dicarboxylic acid dihydrate
Similarity: 0.84
[ 122-05-4 ]
Pyrazine-2,5-dicarboxylic acid
Similarity: 0.84
[ 2435-46-3 ]
3,6-Dimethylpyrazine-2-carboxylic acid
Similarity: 0.81
[ 13515-06-5 ]
5,6-Dimethylpyrazine-2-carboxylic acid
Similarity: 0.86
[ 710322-57-9 ]
Methyl 5-formylpyrazine-2-carboxylate
Similarity: 0.86
[ 940-07-8 ]
Pyrazine-2,6-dicarboxylic acid
Similarity: 0.84
[ 205692-63-3 ]
Pyrazine-2,5-dicarboxylic acid dihydrate
Similarity: 0.84
[ 122-05-4 ]
Pyrazine-2,5-dicarboxylic acid
Similarity: 0.84